These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6660075)

  • 21. Commentary: contrast-induced nephropathy and long-term adverse events: cause and effect?
    McCullough PA
    Nephrol Dial Transplant; 2009 Dec; 24(12):3578-9. PubMed ID: 19783600
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute renal insufficiency as a complication of aortography].
    Belichenko IA; Edel'man LB; Zhuravlev IV; Abugov AM
    Urol Nefrol (Mosk); 1966; 31(3):20-5. PubMed ID: 5995642
    [No Abstract]   [Full Text] [Related]  

  • 23. [Contrast media-associated nephropathy--pathogenesis and prevention].
    Erley CM; Duda SH
    Aktuelle Radiol; 1997 Jul; 7(4):189-92. PubMed ID: 9340015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recommendations for prevention of roentgen contrast medium-induced nephropathy].
    Möckel M; Bahr F; Leuner Ch; Kuhn H; Dietz R
    Z Kardiol; 2002 Sep; 91(9):719-26. PubMed ID: 12448072
    [No Abstract]   [Full Text] [Related]  

  • 25. N-acetylcysteine for contrast nephropathy: more clinical science is required.
    Eddleston M; Goddard J; Bateman N
    Arch Intern Med; 2006 Aug 14-28; 166(15):1668-9; author reply 1669. PubMed ID: 16908804
    [No Abstract]   [Full Text] [Related]  

  • 26. Contrast-associated nephropathy: presentation, pathophysiology and management.
    Porter GA
    Miner Electrolyte Metab; 1994; 20(4):232-43. PubMed ID: 7845325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention.
    Conen D; Buerkle G; Perruchoud AP; Buettner HJ; Mueller C
    Int J Cardiol; 2006 Jun; 110(2):237-41. PubMed ID: 16298441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-induced nephropathy.
    Kabalan SN; El-Imad BG; Geara AS
    J Med Liban; 2007; 55(1):29-38. PubMed ID: 17489305
    [No Abstract]   [Full Text] [Related]  

  • 29. Contrast-induced nephropathy: back to basics.
    Boccalandro F; Anderson HV
    J Invasive Cardiol; 2003 Jun; 15(6):317-8. PubMed ID: 12777669
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute renal failure after venography].
    Castellanos Monedero JJ; Carreño Parrila A; Arrambarri Segura M; Carros Tortosa G
    Nefrologia; 2008; 28(3):357-8. PubMed ID: 18590512
    [No Abstract]   [Full Text] [Related]  

  • 31. Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney.
    Heyman SN; Rosen S; Brezis M
    Exp Nephrol; 1994; 2(3):153-7. PubMed ID: 7922266
    [No Abstract]   [Full Text] [Related]  

  • 32. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T; Sugaya T; Node K; Ueda Y; Koide H
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiocontrast-induced nephropathy.
    Solomon R
    Semin Nephrol; 1998 Sep; 18(5):551-7. PubMed ID: 9754608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute kidney failure developing after the intravenous administration of urotrast].
    Palivoda NI
    Urol Nefrol (Mosk); 1981; (5):63. PubMed ID: 6272462
    [No Abstract]   [Full Text] [Related]  

  • 35. Contrast media induced irreversible acute renal failure in a patient treated with intraperitoneal cisplatin.
    Oymak O
    Clin Nephrol; 1995 Aug; 44(2):135-6. PubMed ID: 8529307
    [No Abstract]   [Full Text] [Related]  

  • 36. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
    Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
    Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences between various glomerular filtration rate calculation methods in predicting patients at risk for contrast-induced nephropathy.
    Eken C; Kilicaslan I
    Am J Emerg Med; 2007 May; 25(4):487. PubMed ID: 17499679
    [No Abstract]   [Full Text] [Related]  

  • 38. Significant statistical heterogeneity in a meta-analysis of the usefulness of acetylcysteine for prevention of contrast nephropathy.
    Faddy SC
    Am J Cardiol; 2004 Aug; 94(3):414. PubMed ID: 15276125
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute renal failure after percutaneous cholangiography.
    Gregory MC
    Arch Intern Med; 1984 Jun; 144(6):1288-9. PubMed ID: 6732387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of pentoxifylline on contrast induced nephropathy.
    Roozbeh J; Hamidian Jahromi A; Sharifian M; Pakfetrat M; Afshariani R
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):985-6. PubMed ID: 18974592
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.